High-Throughput LNP Screening Service
In the rapidly evolving landscape of genomic medicine, the bottleneck has shifted from payload design to delivery vehicle optimization. The chemical space for Lipid Nanoparticles (LNPs) is vast and complex, making traditional iterative testing inefficient. Creative Biolabs addresses this challenge with our premier High-Throughput LNP Formulation Screening Service. By leveraging advanced automated platforms and robust experimental design, we systematically study thousands of formulation variables to identify the ideal vector for your specific therapeutic target. From novel ionizable lipid discovery to tissue-specific delivery, we empower your research with data-driven precision.
Request a Free Scientific Consultation
The Science of High-Throughput LNP Discovery
High-Throughput Screening in LNP Development
The therapeutic efficacy of nucleic acid drugs is dictated by the physicochemical properties of the LNP carrier. However, these properties are non-linearly dependent on multiple variables: lipid structure, molar ratios, payload concentration, and mixing parameters. High-throughput screening (HTS) shifts the paradigm from "rational design based on limited data" to "exploration of the design space." It allows for the unbiased identification of non-intuitive formulations that maximize potency and minimize toxicity, significantly de-risking the development pipeline.
Adopting an HTS approach offers distinct competitive edges in drug development:
The Critical Role of Ionizable Lipid Design
Ionizable lipids are the fundamental enablers of LNP technology, acting as pH-responsive "smart switches" that govern the fate of the therapeutic payload. Their primary function is two-fold: encapsulating nucleic acids via electrostatic interaction during formulation, and facilitating endosomal escape, the rate-limiting step in intracellular delivery. By responding to the acidic environment of the endosome, these lipids undergo a structural transition that destabilizes the membrane and releases the drug into the cytoplasm. The efficacy of this molecular gymnastics is strictly controlled by precise molecular engineering. Key structural factors influencing LNP efficacy include:
Determines the ionization state at physiological pH (neutral) vs. endosomal pH (acidic). An optimal pKa (typically 6.0–7.0) is crucial for endosomal release.
The length, saturation, and branching of lipid tails affect membrane fluidity and fusogenicity with the endosomal membrane.
Biodegradable linkers (e.g., esters) are essential for rapid clearance and reducing systemic toxicity.
The size and charge density of the amine head group influence interaction with the nucleic acid backbone and cellular uptake receptors.
Fig. 1 Selected ionizable lipids under clinical development for COVID-19 mRNA vaccines and other RNA therapeutics.1,3
Integrated High-Throughput LNP Screening Services
By combining cutting-edge automation with deep formulation expertise, Creative Biolabs provide a robust engine for identifying high-performance delivery vectors tailored to your specific payload and therapeutic indication.
To further accelerate your research, we also provide mature, off-the-shelf LNP products, including Empty LNPs, mRNA-LNPs, and specialized Antibody-conjugated LNPs (e.g., Anti-CD3, Anti-CD5, Anti-CD7, Anti-CD8) for targeted delivery applications.
High-Throughput LNP Formulation
Fig. 2 High-throughput combinatorial synthesis and screening of diverse ionizable lipids via multi-component reactions (MCRs).2,4
We utilize advanced liquid handling to construct massive, diverse formulation libraries with unparalleled precision. This automated approach replaces manual pipetting, enabling the systematic evaluation of thousands of lipid combinations with minimal reagent consumption. We help you efficiently explore the design space to find the optimal formulation for your payload.
- Combinatorial Library Design: Strategic Design of Experiments (DoE) to vary critical parameters like lipid molar ratios (N/P), helper lipids, and PEGylation density.
- Precision Automated Mixing: Advanced high-throughput mixing architectures ensure uniform particle formation and consistent physicochemical properties, mimicking scale-up dynamics.
- Diverse Payload Encapsulation: Specialized expertise in encapsulating nucleic acids (mRNA, siRNA, pDNA, Cas9 RNP).
Fig. 3 High-throughput characterization (HTC) methods for LNPs.2,4
Fig. 4 In vitro high-throughput platforms for screening LNP formulations.2,4
Fig. 5 Nucleic acid barcoding strategies for high-throughput in vivo screening of LNP libraries.2,4
Workflow
Applications of High-Throughput Screening
Our HTS capabilities act as a catalyst for diverse research fields, ensuring that your therapeutic payload reaches its intended destination with maximum potency.
- Next-Generation mRNA Vaccines: Rapidly screen lipid ratios to maximize immunogenicity and antigen expression while minimizing reactogenicity and systemic inflammation.
- Precision Gene Editing: Identify formulations that perfectly co-encapsulate Cas9 mRNA and sgRNA for high-efficiency editing in hard-to-transfect stem cells or primary T-cells.
- Targeted Oncology Therapies: Utilize our library to screen for LNPs that selectively accumulate in the tumor microenvironment or target metastasis, reducing off-target toxicity.
- Extra-Hepatic Delivery: Discover novel lipid structures capable of bypassing the liver to target the lungs, spleen, or brain for protein replacement therapies.
- Immunotherapy Optimization: Fine-tune the adjuvant effect of the LNP carrier itself to synergize with cancer vaccines.
Why Choose Creative Biolabs?
At Creative Biolabs, we are dedicated to advancing your therapeutic research through superior high-throughput formulation science. Whether you need a rapid in vitro screen or a complex in vivo optimization campaign, our team is ready to assist.
Deep Chemical Expertise
Access to a curated library of hundreds of ionizable lipids, including novel biodegradable and tissue-specific variants.
Data-Driven Design
We employ Design of Experiments (DoE) methodologies to ensure statistical power and meaningful structure-activity relationship (SAR) insights.
Seamless Scalability
Our screening platforms mimic larger-scale mixing physics, ensuring that "hits" found at the microliter scale are reproducible at the liter scale.
One-stop Analytics
We don't just measure size; we provide a holistic view of stability, pKa, and biological interaction.
Related Services & Products
Related Services
Chemical Synthesis Services
Nucleic Acid Synthesis Services
Related Products
| Product Name | Description | Inquiry |
|---|---|---|
| Targeted LNP Formulation Kit | Selectable organ-specific kits: Liver, Lung, Spleen, Muscle, or Skin targeting. | |
| LNP Formulation Kit (Universal) | All-in-one reagent kit containing lipids and buffers optimized for both manual mixing and standard microfluidic preparation. | |
| LNP Screening Array Kit | A 96-well plate format containing diverse lipid compositions for high-throughput payload screening. | |
| RNA-LNP Encapsulation Assay Kit | Rapid fluorescence-based kit for determining EE% and mRNA concentration. |
FAQs
How does your HTS platform ensure reproducibility?
We utilize automated liquid handling systems that precisely control flow rates and mixing ratios, eliminating human pipetting error. Furthermore, our platform is calibrated to produce particles with consistent size and PDI across replicates.
Can I screen my own proprietary ionizable lipids using your service?
Yes. We offer a "blinded" screening service where we use your proprietary lipids in our high-throughput workflow to optimize formulations without requiring full structural disclosure.
What is the minimum amount of API required for a high-throughput screen?
Our miniaturized screening protocols are highly efficient, typically requiring as little as 1–2 mg of total nucleic acid payload to screen nearly 100 formulations.
Do you offer in vivo screening services?
Yes, we perform high-throughput in vivo screening using DNA barcoding or reporter gene imaging to rapidly assess biodistribution and functional expression in rodent models.
How do you select the lipid library for my specific project?
We select lipids based on your target tissue and payload. For example, for vaccine projects, we prioritize lipids with known immunogenic potential; for gene therapy, we select biodegradable lipids with high hepatocyte potency.
References
- Han, Xuexiang, et al. "An ionizable lipid toolbox for RNA delivery." Nature communications 12.1 (2021): 7233. https://doi.org/10.1038/s41467-021-27493-0.
- Lam, Lois, et al. "High‐Throughput Strategies for Streamlining Lipid Nanoparticle Development Pipeline." Advanced Science 12.42 (2025): e11551. https://doi.org/10.1002/advs.202511551.
- Distributed under Open Access license CC BY 4.0, without modification.
- Distributed under Open Access license CC BY, without modification.
